Induction Period
In-person appointments, twice per week. Appointment length is two hours.
Spravato® Treatment at Innovative Psychedelics
Spravato (Esketamine) is a FDA-approved nasal spray treatment. Spravato offers a novel and effective approach to treating treatment-resistant depression. Administered under the supervision of our experienced team, Spravato targets the brain’s NMDA receptors, influencing neurotransmitter activity to alleviate depressive symptoms.
At Innovative Psychedelics, we prioritize your well-being, tailoring Spravato / Esketamine treatment to your unique needs. Experience the potential for rapid and sustained improvement in mood and mental health. Choose Innovative Psychedelics for expert-guided Spravato (esketamine) treatment that aims to transform your journey towards lasting wellness. Take the first step towards a brighter future—schedule your consultation with us today.
Spravato is an FDA approved medication that may be covered by your insurance. Insurance coverage will only apply if Spravato treatment is administered exactly as directed.
In-person appointments, twice per week. Appointment length is two hours.
In-person appointments, once per week. Appointment length is two hours.
In-person appointments, one every two weeks. Appointment length is two hours.
This treatment protocol must be followed exactly in order for Innovative Psychedelics to be an approved Spravato Administration Center. If you understand the above and would like to use Spravato, please complete this form to schedule a consultation.
Spravato must be administered in-person at an Innovative Psychedelics clinic. You will not get the nasal spray to take home.
You will be monitored for two hours post treatment at our clinic. During this observation period, your blood pressure will be monitored and recorded.
Innovative Psychedelics is required to send a 2-page detailed report to Janssen (the maker of Spravato) regarding any abnormal response.